[MDP] YoY Quarter Result on 30-Sep-2022 [#Q2]

Stock
[MDP] Medexus Pharmaceuticals Inc.
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- -95.28%
YoY- -126.91%
Quarter Report
MDP's Result
MDP's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 30,326 27,686 17,901 17,654 12,386 2,670 2,486 51.69%
PBT -973 -2,541 7,620 -1,797 566 -2,799 -271 23.73%
Tax 120 189 -2,525 -282 69 131 136 -2.06%
NP -1,093 -2,730 10,145 -1,514 497 -2,799 -271 26.15%
Tax Rate - - 33.14% - -12.15% - - -
Total Cost 31,419 30,416 7,756 19,168 11,889 5,469 2,757 49.98%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -3.60 -9.86 56.67 -8.58 4.01 -104.85 -10.92 -16.87%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.05 -0.14 0.53 -0.10 0.04 -0.48 -0.05 0.00%
EPS Diluted -0.05 -0.14 0.52 -0.10 0.03 -0.48 -0.05 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.